Request for Sample
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
3D Bioprinting Market Overview
The Global 3D Bioprinting Market report offers in-depth insights, revenue details, and other vital information regarding the target market and the various trends, drivers, restraints, opportunities, and threats till 2027.
The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, future strategies, acquisitions & mergers, and market footprint. The global 3D bioprinting market is segmented based on technology, application, and region.
Three-dimensional printing of organs and biological tissues by layer-to-layer deposition of living cells to create functional organs and tissues is called 3D bioprinting. 3D bio-printers, bio-ink, and bioprocess protocols create organic materials.
Rising organ transplantation procedures across the globe and increasing funding and investments by major manufacturers in 3d bioprinting technology are major factors driving the growth of the global 3D bioprinting market.
In addition, increasing adoption of 3D bioprinting technology for dental implants, tissue engineering, and drug discovery process is another factor driving the growth of the global market. Increasing adoption of 3D bio-printers in the food sector and in the cosmetic industry is expected to further propel the growth of the target market to a significant extent over the forecast period.
In addition, using 3D bioprinting technology could prevent cell rejection in the case of organ transplantation and could also replace humans and animals in lab testing procedures. These advantages of 3D bioprinting technology are expected to further fuel the growth of the global market over the forecast.
The high cost of bioprinting devices and high treatment costs are major factors hampering the growth of the global 3D bioprinting market. In addition, the lack of skilled professionals and awareness about 3D bioprinting technology in some developing and underdeveloped countries are other factors hampering the growth of the global market.
The north American market dominates the global 3D bioprinting market in terms of revenue and is expected to maintain its dominance over the forecast period. This growth can be attributed to rising investments in R&D of bioprinting technology by public and private players, early adoption of this technology owing to a well-developed healthcare system, and high disposable income of individuals in countries in this region.
The Europe 3D bioprinting market is the second-highest globally position and is expected to witness considerable growth over the next 10 years. The market in the Asia Pacific is expected to witness significant growth in terms of revenue and is projected to register a CAGR of XX.X% over the next 10 years.
This growth can be attributed to rapid development in healthcare infrastructure and the rising adoption of advanced healthcare technology in countries such as India, China, Japan, etc.
Global 3D bioprinting Market Segmentation:
Segmentation on the basis of technology:
- Magnetic Levitation
- Inkjet Based
- Syringe Based
Segmentation on the basis of application:
- Consumer/Personal Product Testing
- Food and Animal Product Bioprinting
Segmentation on the basis of region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Organovo Holdings Inc.
- Cyfuse Biomedical K.K.
- EnvisionTEC GmbH
- Allevi Inc.
- Nano3D Biosciences Inc.
- 3Dynamic Systems Ltd.
- Aspect Biosystems Ltd.
- Regenovo Biotechnology Co. Ltd.
- TeVido BioDevices
- Bio3D Technologies
Request for TOC
Don't just take our word. We are trusted by these great companies!